News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Take-Two Interactive Software CEO Strauss Zelnick sold 40,000 shares of the company's stock for over $10.1 million. This sale follows larger transactions in recent months, despite the company's Q1 results showing a per-share loss but exceeding revenue expectations. Analysts largely maintain a "Buy" rating …
Sharemaestro market context Trend signal active 52 weeks -2.8%Strauss Zelnick, CEO of Take-Two Interactive Software Inc., sold 39,900 shares of company stock worth approximately $10.1 million on August 10, 2026, when shares were trading near their 52-week high. These sales were conducted indirectly through the Zelnick Belzberg Living Trust and the Zelnick …
Take-Two Interactive Software Inc. (TTWO) stock fell 1.21% on Tuesday, closing at $250.50. This underperformance occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also experiencing declines. The stock's drop ended a two-day winning streak.
Quaker Chemical Corp's EVP, Jeewat Bijlani, reported the forfeiture of 7 shares of common stock on August 7, 2026. These shares were previously escrowed to secure indemnification obligations related to the acquisition of Global Houghton Ltd. The forfeiture occurred upon the resolution of these …
The cloud data-platform stock remains in a strong weekly setup, but participation and Relative Strength leave the read short of clean confirmation.
Take-Two Interactive's CEO, Strauss Zelnick, had trusts associated with him sell 40,000 shares of common stock on August 10, 2026, for over $10 million. Additionally, 20,000 shares were transferred as bona fide gifts between related trusts. The transactions, filed via a Form 4, show …
The Cheesecake Factory (CAKE) is currently deemed 111.3% overvalued by GuruFocus's GF Value™ metric, trading at $112.95 against an intrinsic value of $53.45. This significant overvaluation is further supported by its high P/E ratio compared to its historical median and a low growth rank, …
Lakefront Biotherapeutics (NASDAQ:LKFT) has received an average "Hold" rating from analysts, with a consensus 12-month price target of $34.33. The company recently surpassed earnings expectations, reporting an EPS of $0.04 against an anticipated loss of $0.97, and revenue of $15.47 million, significantly higher than …
North America Breaks Rig Addition Streak·rigzone.com This article was first published on Rigzone here North America dropped three rigs week on week, according to Baker Hughes' latest North America rotary rig count, which was released on August 7. The total U.S. rig count stayed …
MakeMyTrip (MMYT) is currently considered undervalued by 13.9% at a share price of US$60.91, following its Q1 FY 2027 results and the launch of its AI travel assistant Myra 2.0. The company's valuation is driven by expectations of accelerated revenue growth, improved profitability, and …
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …
Lakeland Industries Inc. (NASDAQ: LAKE) shows mixed sentiment, suggesting choppy market conditions. The article outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. It highlights the absence of resistance levels above the current price, indicating potential upside.
Baker Hughes Company (NASDAQ:BKR) shares jumped more than 6% after the company beat second-quarter profit estimates and posted record orders, even as it warned that oil and gas producers will spend modestly less this year. Earnings per share came in at 64 cents, well …
JPMorgan Chase & Co. has reiterated its "overweight" rating and set a $310 price target for Take-Two Interactive Software (NASDAQ:TTWO), indicating a potential 22% upside. This follows a quarter where the company exceeded revenue expectations but missed on EPS. The upcoming GTA VI launch …
RBC has lowered its price target for Lakefront Biotherapeutics (LKFT) to $26 from $28, while maintaining a "Sector Perform" rating on the stock. This adjustment reflects a revised outlook from the analyst firm. The article, published on MarketScreener, notes that details are reserved for …
Baker Hughes Agreement positions Baker Hughes as key technology collaborator in KOC's innovation ecosystem Tech focus will be on innovative, fit-for-purpose solutions, including digital and AI automation, to address KOC's challenges and production priorities Baker Hughes commits to dedicated research and development center in …
Baker Hughes has secured a contract from Searah North Ganal to supply subsea production systems and digital solutions for the Kutei Northern Hub development in Indonesian waters. Searah North Ganal is a subsidiary of Searah, a joint venture between Eni and PETRONAS. The contract …
LA DÉFENSE, France, August 11, 2026--(BUSINESS WIRE)--Regulatory News: In accordance with applicable regulations, Arkema (Paris:AKE) announces having carried out the following share buyback transactions in accordance with Article 5 §2 of Regulation (EU) No 596/2014 from 03 August to 07 August 2026 Name of …
Sharemaestro market context Trend signal active 52 weeks +3.5%Sei Investments Co. significantly reduced its stake in Westlake Corporation (NYSE:WLK) during the first quarter by selling 15,673 shares, leaving them with 12,769 shares valued at $1.49 million. Despite institutional investors collectively owning 28.4% of WLK, analysts maintain a "Hold" rating with an average …
In late July and early August 2026, Alteryx, Aembit, and 1Password announced new integrations with Snowflake's AI Data Cloud and security ecosystem, while Snowflake launched Cortex AI Gateway to help enterprises govern, secure, and orchestrate both first- and third-party AI agents at scale. Together, …
Sharemaestro market context Trend signal active 52 weeks +50.2%Lakefront Biotherapeutics NV announced its earnings results for the half year ended June 30, 2026. The company reported a significant decrease in revenue to EUR 18.6 million from EUR 140.3 million a year ago, but achieved a net income of EUR 16.6 million, a …
Despite what might appear to be soft profit numbers, MakeMyTrip Limited (NASDAQ:MMYT) earnings are more promising due to a strong accrual ratio of -0.20 for June 2026, indicating significant free cash flow generation. The company reported $153m in free cash flow, considerably more than …
Westlake (WLK) is gaining investor attention after reporting a return to profitability in Q2 2026, driven by higher pricing, lower costs, and cost savings. While its stock has seen a recent rebound, its 3-year return remains negative, and conflicting valuation models exist. One popular …
Takeda Korea has appointed Kim Mi-seung, previously head of its oncology business unit, as its new representative director. This appointment fills a two-month vacancy left after the former General Manager, Park Kwang-kyu, stepped down in June. Kim brings over two decades of experience in …
CWK Q2 Deep Dive: Organic Growth, Data Center Expansion, and Balanced Outlook Real estate services firm Cushman & Wakefield (NYSE:CWK) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 11.2% year on year to $2.76 billion. Its non-GAAP profit of …
Lakefront Biotherapeutics reported a net profit of €16.6 million for H1 2026, a significant turnaround from a €259.1 million loss in H1 2025, primarily due to reduced R&D costs and positive fair value adjustments. The company completed the acquisition of Ouro Medicines, maintains a …
In the latest trading session, Snowflake Inc. (SNOW) closed at $334.70, marking a +1.27% move from the previous day. This move outpaced the S&P 500's daily loss of 0.06%. Elsewhere, the Dow saw a downswing of 0.11%, while the tech-heavy Nasdaq depreciated by 0.32%. …
Sharemaestro market context Trend signal active 52 weeks +50.2%Lakefront Biotherapeutics reported a significant drop in H1 FY26 net sales by 87% to €18.6 million, though it swung to a net profit of €16.6 million and narrowed its operating loss by 54% to €107.2 million. The company's R&D and SG&A expenses also decreased, …
Search by ticker symbol or company name and select a result to open its chart.